21:02 , Jan 27, 2017 |  BC Week In Review  |  Company News

Regeneus, Asahi Glass deal

Regeneus Ltd. (ASX:RGS), Pymble, Australia  Asahi Glass Co. Ltd. (Tokyo:5201), Tokyo, Japan  Business: Autoimmune, Gene/Cell therapy  Regeneus and Asahi Glass formed a 50/50 JV to develop and commercialize osteoarthritis candidate Progenza in Japan. Regeneus received...
07:00 , Apr 28, 1997 |  BC Week In Review  |  Clinical News

Integra Life Sciences Corp., Asahi Glass Co., The Burnham Institute, Merck, SmithKline regulatory update

The Board of Patent Appeals and Interferences of the U.S. Patent and Trademark Office ruled that Michael Pierschbacher, senior vice president of R&D at IART, and Burnham Institute President Erkki Ruoslahti, a consultant to the...